AT2 receptor activities and pathophysiological implications

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 3, 2015, Pages 226-232

  Matavelli, Luis C ^a   Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

angiotensin II subtype 1 receptor; angiotensin II subtype 2 receptor; renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR AGONIST; BRADYKININ; HORMONE RECEPTOR STIMULATING AGENT; NITRIC OXIDE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CARDIOVASCULAR AGENT; NEUROPROTECTIVE AGENT;

ARTICLE; BLOOD PRESSURE; BRAIN FUNCTION; DRUG EFFECT; HEART; HUMAN; INFLAMMATION; KIDNEY; KIDNEY BLOOD FLOW; NATRIURESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; VASCULAR REMODELING; VASODILATATION; AGONISTS; ANIMAL; BRAIN; CARDIOVASCULAR SYSTEM; DRUG DESIGN; DRUG EFFECTS; FIBROSIS; HEART VENTRICLE REMODELING; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; DRUG DESIGN; FIBROSIS; HUMANS; KIDNEY; MOLECULAR TARGETED THERAPY; NEUROPROTECTIVE AGENTS; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84925466903     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000208     Document Type: Article

References (90)

1. Kambayashi Y, Bardhan S, Takahashi K, et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-25546.
2. Mukoyama M, Nakajima M, Horiuchi M, et al. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seventransmembrane receptors. J Biol Chem. 1993;268:24539-24542.
3. Siragy HM. AT1 and AT2 receptor in the kidney: role in health and disease. Semin Nephrol. 2004;24:93-100.
4. Reudelhuber T. The continuing saga of the AT2 receptor. A case of the good, the bad, and the innocuous. Hypertension. 2005;46: 1261-1262.
5. Carey RM. Cardiovascular and renal regulation by the angiotensin II type 2 receptor-the AT(2) receptor comes of age. Hypertension. 2005; 45:840-844.
6. Bosnyak S, Jones ES, Christopoulos A, et al. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci. 2011;121:297-303.
7. Padia SH, Howell NL, Siragy HM, et al. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension. 2006;47:537-544.
8. Koike G, Horiuchi M, Yamada T, et al. Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem Biophys Res Commun. 1994;203: 1842-1850.
9. VanAtten MK, Ensinger CL, Chiu AT, et al. A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site. J Med Chem. 1993;36:3985-3999.
10. Kijima K, Matsubara H, Murasawa S, et al. Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension. 1996;27:529-534.
11. Kambayashi Y, Ichild T, Inagami T. Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular smooth muscle cells. Eur J Biochem. 1996;239:558-565.
12. Ichiki T, Kambayashi Y, Inagami T. Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells. Circ Res. 1995;77:1070-1076.
13. Endo Y, Arima S, Yaoita H, et al. Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int Suppl. 1997;63:S205-S207.
14. Jones A, Dhamrait SS, Payne JR, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension. 2003; 42:500-506.
15. Gribouval O, Gonzales M, Neuhaus T, et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet. 2005;37:964-968.
16. Tsuchida S, Matsusaka T, Chen X, et al. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest. 1998;101: 755-760.
17. Oliverio MI, Kim HS, Ito M, et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A. 1998;95: 15496-15501.
18. Nishimura H, Yerkes E, Hohenfellner K, et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell. 1999;3:1-10.
19. Sales VL, Sukhova GK, Lopez-Ilasaca MA, et al. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation. 2005;112:3328-3336.
20. Li Y, Li XH, Yuan H. Angiotensin II type-2 receptor-specific effects on the cardiovascular system. Cardiovasc Diagn Ther. 2012;2:56-62.
21. Yu L, Zheng M, Wang W, et al. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin Angiotensin Aldosterone Syst. 2010;11:214-221.
22. Song R, Spera M, Garrett C, et al. Angiotensin II AT2 receptor regulates ureteric bud morphogenesis. Am J Physiol Renal Physiol. 2010;298: F807-F817.
23. Ozono R, Wang ZQ, Moore AF, et al. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension. 1997; 30:1238-1246.
24. Myiata N, Park F, Li XF, et al. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol Renal Physiol. 1999; 277:F437-F446.
25. Ruiz-Ortega M, Esteban V, Suzuki Y, et al. Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int Suppl. 2003;86:S21-S26.
26. Levy BI. How to explain the differences between renin angiotensin system modulators. Am J Hypertens. 2005;18:134S-141S.
27. Xu Y, Hu X, Wang L, et al. Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair. PLoS One. 2013;8:e82997.
28. Fischer TA, Singh K, Ohara DS, et al. Role of AT1 and AT2 receptors in regulation of MAPKS and MKP-1 by Ang II in adult cardiac myocytes. Am J Physiol. 1998;44:H906-H916.
29. Matsubara H, Inada M. Molecular insights into angiotensin II type 1 and type 2 receptors-Expression, signaling and physiological function and clinical application of its antagonists. Endocr J. 1998;45: 137-150.
30. Hayashida W, Horiuchi M, Dzau VJ. Intracellular third loop domain of angiotensin II type-2 receptor-Role in mediating signal transduction and cellular function. J Biol Chem. 1996;271:21985-21992.
31. Zhang JS, Pratt RE. The AT2 receptor selectively associates with Gia2 and Gia3 in the rat fetus. J Biol Chem. 1996;271:15026-15033.
32. Siragy HM, Carey RM. The subtype-2 (AT2) angiotensin receptor regulates renal cycle guanosine 30, 50-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest. 1996;97:1978-1982.
33. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997; 100:264-269.
34. Abadir PM, Carey RM, Siragy HM. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension. 2003;42:600-604.
35. Abadir PM, Periasamy A, Carey RM, et al. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension. 2006;48:316-322.
36. Batenburg WW, Garrelds IM, Bernasconi CC, et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation. 2004;109:2296-2301.
37. Savoia C, Touyz RM, Volpe M, et al. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension. 2007;49:341-346.
38. Kaschina E, Grzesiak A, Li J, et al. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the reninangiotensin system in myocardium infarction? Circulation. 2008;118: 2523-2532.
39. Gelosa P, Pignieri A, Fändriks L, et al. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens. 2009;27:2444-2451.
40. Matavelli LC, Huang J, Siragy HM. Angiotensin II type 2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension. 2011;57:308-313.
41. Foulquier S, Steckelings UM, Unger T. Impact of the AT2 receptor agonist C21 on blood pressure and beyond. Curr Hypertens Rep. 2012;14;403-409.
42. Katada J, Majima M. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol. 2002;136:484-491.
43. Cosentino F, Savoia C, De Paolis P, et al. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens. 2005;18(4 pt1):493-499.
44. Widdop RE, Matrougui K, Levy BI, et al. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension. 2002;40;516-520.
45. Siragy HM, Inagami T, Ichiki T, et al. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A. 1999;96:6506-6510.
46. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
47. Hein L, Barsh GS, Pratt RE, et al. Behavioral and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 1995;377:744-747.
48. Whitebread SE, Taylor V, Bottari SP, et al. Radioiodinated CGP 42112A: a novel high affinity and highly selective ligand for the characterization of angiotensin AT receptors. Biochem Biophys Res Commun. 1991;181:1365-1371.
49. Whitebread S, Mele M, Kamber B, et al. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;163:284-291.
50. Blankley CJ, Hodges JC, Klutchko SR, et al. Synthesis and structureactivity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem. 1991;34:3248-3260.
51. Gross V, Schunck WH, Honeck H, et al. Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int. 2000;57:191-202.
52. Siragy HM, Carey RM. Protective role of the AT2 receptor in a renal wrap hypertension model. Hypertension. 1999;33:1237-1242.
53. Siddiqui AH, Ali Q, Hussain T. Protective role of the angiotensina II subtype 2 receptor in blood pressure increase in obese Zucker rats. Hypertension. 2009;53:256-261.
54. Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol. 2001;134:865-870.
55. Yayama K, Horii M, Hiyoshi H, et al. Up-regulation of angiotensina type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther. 2004;308:736-743.
56. Wan Y, Wallinder C, Plouffe B, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem. 2004;47:5995-6008.
57. Wagenaar GT, Laghmani el H, Fidder M, et al. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2013;305:L341-L351.
58. Jones ES, Del Borgo MP, Kirsch JF, et al. A single beta-amino acid substitution to angiotensin II confers AT2 receptor selectivity and vascular function. Hypertension. 2011;57:570-576.
59. Rosenström U, Sköld C, Plouffe B, et al. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists. J Med Chem. 2005;48:4009-4024.
60. Danyel LA, Schmerler P, Paulis L, et al. Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure. Integr Blood Control. 2013;6:153-161.
61. Murugaiah AM, Wu X, Wallinder C, et al. From the first selective nonpeptide AT(2) receptor agonist to structurally related antagonists. J Med Chem. 2012;55:2265-2278.
62. Verdonk K, Durik M, Abd-Alla N, et al. Compound 21 induces vasorelaxation via an endothelium-and angiotensin II type 2 receptorindependent mechanism. Hypertension. 2012;60:722-729.
63. Rehman A, Leibowitz A, Yamamoto N, et al. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension. 2012;59: 291-299.
64. Gao J, Zucker IH, Gao L. Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure. Am J Hypertens. 2014;27:1248-1256.
65. Jehle AB, Xu Y, Dimaria JM, et al. A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice. J Cardiovasc Pharmacol. 2012;59: 363-368.
66. Rompe F, Artuc M, Hallberg A, et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension. 2010;55: 924-931.
67. Hilliard LM, Nematbakhsh M, Kett MM, et al. Gender differences in pressure-natriuresis and renal autoregulation: role of the angiotensin type 2 receptor. Hypertension. 2011;57:275-282.
68. Hilliard LM, Jones ES, Steckelings UM, et al. Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension. 2012;59:409-414.
69. Hilliard LM, Chow CL, Mirabito KM, et al. Angiotensin type 2 receptor stimulation increases renal function in female, but not male, spontaneously hypertensive rats. Hypertension. 2014;64:378-383.
70. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199-1208.
71. Silva-Antonialli MM, Tostes RC, Fernandes L, et al. A lower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res. 2004;62:587-593.
72. Brouwers S, Smolders I, Massie A, et al. Angiotensin II type 2 receptormediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo. Hypertension. 2013;62: 920-926.
73. Ali Q, Wu Y, Hussain T. Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats. Kidney Int. 2013;84:931-939.
74. Matrougui K, Levy BI, Henrion D. Tissue angiotensin II and endothelin modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br J Pharmacol. 2000;130:521-526.
75. Endo Y, Arima S, Yaoita H, et al. Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vasc Res. 1998;35:421-427.
76. Bosnyak S, Welungoda IK, Hallberg A, et al. Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol. 2010;159:709-716.
77. Carey RM, Howell NL, Jin X-H, et al. Angiotensin type-2 receptormediated hypotension in angiotensin type-1 receptor blocked rats. Hypertension. 2001;38:1272-1277.
78. Barber MN, Sampey DB, Widdop RE. AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension. 1999;34:1112-1116.
79. Gao L, Wang WZ, Wang W, et al. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension. 2008;52:708-714.
80. Gao J, Zhang H, Le KD, et al. Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats. Am J Hypertens. 2011;24:724-730.
81. Pinaud F, Bocquet A, Dumont O, et al. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension. 2007;50: 96-102.
82. Paulis L, Becker ST, Lucht K, et al. Direct angiotensin II type 2 receptor stimulation in Nv-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension. 2012;59:485-492.
83. Kljajic ST, Widdop RE, Vinh A, et al. Direct AT2 receptor stimulation is athero-protective and stabilizes plaque in Apolipoprotein E-deficient mice. Int J Cardiol. 2013;169:281-287.
84. Iwai M, Liu HW, Chen R, et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation. 2004; 110:843-848.
85. McCarthy CA, Vinh A, Callaway JK, et al. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke. 2009;40:1482-1489.
86. Li J, Culman J, Hortnagl H, et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 2005;19: 617-619.
87. Jing F, Mogi M, Sakata A, et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab. 2012; 32:248-255.
88. Min LJ, Mogi M, Tsukuda K, et al. Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage. Am J Hypertens. 2014;27:1036-1044.
89. McCarthy CA, Vinh A, Miller AA, et al. Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats. PLoS One. 2014;9:e95762.
90. Joseph JP, Mecca AP, Regenhardt RW, et al. The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke. Neuropharmacology. 2014;81:134-141.